Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 202, pseudogene (RN7SL202P)
- Target
- RN7SL202P
- Molecular classification
- Pseudogene, Non-coding RNA-derived element, Other
01
Overview
RN7SL202P is classified as a *pseudogene* derived from 7SL RNA, which forms part of the signal recognition particle (SRP) involved in protein targeting to the endoplasmic reticulum[4][6]. Pseudogenes like RN7SL202P are sequenced fragments of DNA that resemble functional genes but generally lack coding potential and are not transcribed into functional proteins. The 7SL RNA gene family is characterized by numerous pseudogene variants in the human genome, with most pseudogene copies being non-functional. Specific 7SL pseudogenes arise from reverse transcription and genomic insertion events, resulting in truncated, rearranged, or otherwise non-functional forms[4][6]. *No functional or therapeutic relevance has been ascribed to RN7SL202P by major databases or research articles. It should not be considered a canonical drug target, biomarker, or clinically actionable molecule.*
- Other names
- RN7SL202PRNA, 7SL, cytoplasmic 202, pseudogene
02
Biological functions
Other
03
Disease associations
Other
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 202, pseudogene (RN7SL202P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 202, pseudogene (RN7SL202P).